Share. Connect. Create. Grow. · Socialiya
UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative me...

BUSINESS NEWS April 17, 2026

UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative medicine and advanced therapies," the company said.

20 views 0 likes 0 comments
Share:
Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative medicine and advanced therapies," the company said.

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya